Edition:
United States

People: C R Bard Inc (BCR)

BCR on New York Consolidated

223.74USD
29 Sep 2016
Change (% chg)

$-3.56 (-1.57%)
Prev Close
$227.30
Open
$226.69
Day's High
$227.26
Day's Low
$222.87
Volume
682,766
Avg. Vol
461,275
52-wk High
$239.43
52-wk Low
$172.21

DeFord, John 

Dr. John A. DeFord, Ph.D., is Senior Vice President-Science, Technology and Clinical Affairs of Company. He joined Bard in 2004 as Vice President, Science & Technology after serving as Managing Director with Early Stage Partners, LLP (ESP), a venture capital fund, from 2002 until 2004. Before joining ESP he was President and CEO of Cook Incorporated, a privately-held medical device company. He was promoted to Senior Vice President-Science, Technology & Clinical Affairs in 2007.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Timothy Ring

11,744,800

John Weiland

6,920,670

Jim Beasley

3,827,980

Timothy Collins

3,909,070

John Groetelaars

--

Christopher Holland

3,652,540
As Of  30 Dec 2015